NeuroSense Therapeutics Stock Forecast - Accumulation Distribution
| NRSNW Stock | USD 0.34 0 0.59% |
NeuroSense Stock outlook is based on your current time horizon.
At this time, the RSI of NeuroSense Therapeutics' share price is approaching 46. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling NeuroSense Therapeutics, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
Using NeuroSense Therapeutics hype-based prediction, you can estimate the value of NeuroSense Therapeutics Ltd from the perspective of NeuroSense Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
NeuroSense Therapeutics after-hype prediction price | USD 0.44 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NeuroSense | Build AI portfolio with NeuroSense Stock |
NeuroSense Therapeutics Additional Predictive Modules
Most predictive techniques to examine NeuroSense price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NeuroSense using various technical indicators. When you analyze NeuroSense charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check NeuroSense Therapeutics Volatility | Backtest NeuroSense Therapeutics | Information Ratio |
NeuroSense Therapeutics Trading Date Momentum
| On January 26 2026 NeuroSense Therapeutics Ltd was traded for 0.34 at the closing time. The highest daily price throughout the period was 0.34 and the lowest price was 0.34 . There was no trading activity during the period 0.0. Lack of trading volume on 01/26/2026 did not cause price change. The trading delta at closing time to current closing price is 0.58% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare NeuroSense Therapeutics to competition
NeuroSense Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeuroSense Therapeutics stock to make a market-neutral strategy. Peer analysis of NeuroSense Therapeutics could also be used in its relative valuation, which is a method of valuing NeuroSense Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
NeuroSense Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how NeuroSense Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuroSense Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuroSense Therapeutics stock market strength indicators, traders can identify NeuroSense Therapeutics Ltd entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 0.34 | |||
| Day Typical Price | 0.34 | |||
| Price Action Indicator | 0.003 | |||
| Period Momentum Indicator | 0.002 | |||
| Relative Strength Index | 46.79 |
NeuroSense Therapeutics Risk Indicators
The analysis of NeuroSense Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NeuroSense Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neurosense stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 13.14 | |||
| Semi Deviation | 14.77 | |||
| Standard Deviation | 19.88 | |||
| Variance | 395.15 | |||
| Downside Variance | 312.43 | |||
| Semi Variance | 218.15 | |||
| Expected Short fall | (17.89) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for NeuroSense Therapeutics
The number of cover stories for NeuroSense Therapeutics depends on current market conditions and NeuroSense Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NeuroSense Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NeuroSense Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
NeuroSense Therapeutics Short Properties
NeuroSense Therapeutics' future price predictability will typically decrease when NeuroSense Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of NeuroSense Therapeutics Ltd often depends not only on the future outlook of the potential NeuroSense Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NeuroSense Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.6 M | |
| Cash And Short Term Investments | 3.4 M |
Additional Tools for NeuroSense Stock Analysis
When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.